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Background: Many breast cancer patients and survivors use yoga to cope with their disease. The aim of this review
was to systematically assess and meta-analyze the evidence for effects of yoga on health-related quality of life and
psychological health in breast cancer patients and survivors.
Methods: MEDLINE, PsycInfo, EMBASE, CAMBASE, and the Cochrane Library were screened through February 2012.
Randomized controlled trials (RCTs) comparing yoga to controls were analyzed when they assessed health-related
quality of life or psychological health in breast cancer patients or survivors. Risk of bias was assessed using the
Cochrane risk of bias tool. Standardized mean differences (SMD) and 95% confidence intervals (CI) were calculated.
Results: Twelve RCTs with a total of 742 participants were included. Seven RCTs compared yoga to no treatment; 3
RCTs compared yoga to supportive therapy; 1 RCT compared yoga to health education; and 1 RCT compared a
combination of physiotherapy and yoga to physiotherapy alone. Evidence was found for short-term effects on
global health-related quality of life (SMD= 0.62 [95% CI: 0.04 to 1.21]; P = 0.04), functional (SMD= 0.30 [95% CI: 0.03
to 0.57), social (SMD= 0.29 [95% CI: 0.08 to 0.50]; P < 0.01), and spiritual well-being (SMD= 0.41 [95% CI: 0.08; 0.74];
P = 0.01). These effects were, however, only present in studies with unclear or high risk of selection bias. Short-term
effects on psychological health also were found: anxiety (SMD=−1.51 [95% CI: -2.47; -0.55]; P < 0.01), depression
(SMD=−1.59 [95% CI: -2.68 to −0.51]; P < 0.01), perceived stress (SMD=−1.14 [95% CI:-2.16; -0.12]; P = 0.03), and
psychological distress (SMD=−0.86 [95% CI:-1.50; -0.22]; P < 0.01). Subgroup analyses revealed evidence of efficacy
only for yoga during active cancer treatment but not after completion of active treatment.
Conclusions: This systematic review found evidence for short-term effects of yoga in improving psychological
health in breast cancer patients. The short-term effects on health-related quality of life could not be clearly
distinguished from bias. Yoga can be recommended as an intervention to improve psychological health during
breast cancer treatment.
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ReviewBackground
Breast cancer is the most frequent cancer in women
worldwide with more than 1.5 million new cases in
2008. Twenty-three percent of all female cancer cases
were diagnosed with breast cancer [1]. Due to improved
diagnosis and treatment, there is a continuous increase
in survival rates [2]. However, cancer patients often ex-
perience side effects during treatment [3]. Many of them* Correspondence: h.cramer@kliniken-essen-mitte.de
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reproduction in any medium, provided the orare bothered by reduced health-related quality of life
and decreased psychological health that may persist even
after the end of active treatment [4]. Depression and
anxiety are the most common psychological complaints
in cancer patients and survivors [5] and may arise from
psychological distress; this is the inability to cope with
the stress of cancer symptoms and treatment [6]. Sub-
stantial psychological distress is present in 1 of every 3
breast cancer patients [3]. Psychosocial problems can ag-
gravate symptom burden and seriously affect health-
related quality of life [7]. Health-related quality of life
describes the general well-being or global health of aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Complete search strategy for Medline
Concept Search strategy
Yoga (yoga[MeSH Terms] OR yog*[Title/Abstract])
AND
Health-related
quality of life or
psychological health
(quality of life[MeSH Terms] OR quality of
life[Title/Abstract] OR well-being[Title/Abstract]
OR mental health[MeSH Terms] OR mental
health[Title/Abstract] OR psychological
health[Title/Abstract] OR anxiety[MeSH Terms]
OR anxiety[Title/Abstract] OR depressive
disorder[MeSH Terms] OR depression
[Title/Abstract] OR stress[Title/Abstract] OR
distress[Title/Abstract] OR affect[MeSH Terms]
OR mood[Title/Abstract])
AND
Breast cancer (breast neoplasms[MeSH Terms] OR (breast[Title/
Abstract] AND (neoplasms[Title/Abstract] OR
cancer[Title/Abstract] OR oncology[Title/Abstract])))
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physical, mental, and spiritual well-being, role function-
ing and social support [7].
In order to cope with the disease, many breast cancer
patients and survivors use complementary medicine [8]
and yoga is among the most commonly used comple-
mentary treatments for breast cancer-related impair-
ments [8]. Derived from ancient Indian philosophy, yoga
comprises advice for ethical lifestyle, as well as spiritual
practice and physical postures, with the ultimate goal of
uniting mind, body and spirit [9]. In North America and
Europe, yoga is most often associated with physical exer-
cises (asanas), breathing techniques (pranayama) and
meditation (dyana) [10]. An estimated 15 million American
adults report having practiced yoga at least once in their
lifetime, almost half of those using yoga explicitly for
coping with disease or promoting health [11].
Previously, meta-analyses concluded that conventional
physical activity can improve quality of life in breast can-
cer patients and survivors [12-14]. However, while sys-
tematic reviews and meta-analyses have shown similar
results for yoga in heterogeneous cancer groups [15,16],
there is no meta-analysis on yoga for breast cancer
patients or survivors yet. Since patients with different
types of cancer are heterogeneous in terms of socio-
demographic factors, symptoms, treatment and side
effects, meta-analyses should focus on homogenous can-
cer groups [12].
This systematic review focused on the effect of yoga
on health-related quality of life and psychological health
in breast cancer patients and survivors.Methods
PRISMA guidelines for systematic reviews and meta-
analyses [17] and the recommendations of the Cochrane
Collaboration [18] were followed.Literature search
Pubmed/Medline, EMBASE, the Cochrane Library,
PsycINFO, and CAMBASE were searched from their in-
ception until February 2012 without language restrictions.
Search terms for yoga were combined with search terms
for health-related quality of life or psychological health and
with search terms for breast cancer. The search strategy
was adapted for each database as necessary. The complete
search strategy for Pubmed/Medline is shown in Table 1.
Reference lists of identified original and review papers also
were reviewed. Additionally, the table of contents of the
International Journal of Yoga Therapy was reviewed.
Abstracts identified during literature search were
screened by 3 authors independently. Retrieved articles
were read in full by 3 authors to determine whether they
met the eligibility criteria.Inclusion criteria
To be eligible, studies had to meet the following
conditions:
1) Types of studies. Randomized controlled trials (RCTs)
were eligible. Studies were eligible only if they were
published as full paper.
2) Types of participants. Studies of adult (older than
18 years) patients with a history of breast cancer
were eligible.
3) Types of interventions. Studies that compared yoga
with no treatment or any active treatment were
eligible. Studies were excluded if yoga was not the
main intervention but a part of a multimodal
intervention, such as mindfulness-based stress
reduction (for a meta-analysis of mindfulness-based
stress reduction for breast cancer patients and
survivors see [19]). No restrictions were made
regarding yoga tradition, length, frequency or
duration of the program. Co-interventions were
allowed.
4) Types of outcome measures. Studies were eligible if
they assessed health-related quality of life or well-
being (global health-related quality of life, mental,
physical, functional, social, and/or spiritual well-
being) and/or psychological health (depression,
anxiety, perceived stress, and/or psychological
distress). If available, safety data served as secondary
outcome measures.Data extraction
Three reviewers independently extracted data on charac-
teristics of the study (e.g. trial design, randomization,
blinding), characteristics of the patient population (e.g.
sample size, stage of cancer, current treatment, age),
characteristics of the intervention and control (e.g. type,
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sures and results.
Risk of bias in individual studies
Risk of bias was assessed by 2 authors independently
using the Cochrane risk of bias tool [18]. This tool
assesses risk of bias on the following domains: selection
bias, performance bias, detection bias, attrition bias,
reporting bias, and other bias. Discrepancies were
rechecked with a third reviewer and consensus achieved
by discussion.
Data analysis
Studies were analyzed separately for short-term and
long-term follow-ups. For the purpose of this review,
short-term follow-up was defined as outcome measures
taken closest to the end of the intervention and long-
term follow-up as measures taken closest to 12 months
after randomization [20].
Assessment of overall effect size
If at least two studies were available on a specific out-
come, data for this outcome was included in the meta-
analysis. Overall effects were analyzed using Review
Manager 5 software (Version 5.1, The Nordic Cochrane
Centre, Copenhagen). A random effects model was used
because it involves the assumption of statistical hetero-
geneity between studies [18].
As a specific outcome could be measured on different
scales, standardized mean differences (SMD) with 95%
confidence intervals (CI) were calculated. SMD was cal-
culated as the difference in means between groups
divided by the pooled standard deviation. Where no
standard deviations were available, they were calculated
from standard errors, confidence intervals or t values
[18], or attempts were made to obtain the missing data
from the trial authors by email. The effect size used in
this review is also known in social science as Hedges'
(adjusted) g. Cohen's categories were used to evaluate
the magnitude of the effect size with small, moderate
and large effect sizes being defined as SMD=0.2 to 0.5,
SMD=0.5 to 0.8 and SMD>0.8, respectively [21].
A positive SMD was defined to indicate beneficial
effects of yoga compared to the control intervention for
health-related quality of life (e.g. increased well-being),
while a negative SMD was defined to indicate beneficial
effects for the other outcomes (e.g. decreased depres-
sion). If necessary, scores were inverted by subtracting
the mean from the maximum score of the instrument
[18].
Assessment of heterogeneity
Heterogeneity was explored using the I2 statistics, a
measure of how much variance between studies can beattributed to differences between studies rather than
chance. I2 > 50% was regarded to indicate strong hetero-
geneity [18]. The Chi2 test was used to assess whether
differences in results are compatible with chance alone.
Since this test has low power when only few studies or
studies with low sample size are included in a meta-
analysis, a p value ≤ 0.10 was regarded to indicate sig-
nificant heterogeneity [18].
Subgroup and sensitivity analyses
Besides assessment of overall effect, subgroup analyses
were conducted for type of yoga intervention (yoga in-
cluding physical activity/asanas; yoga not including
physical activity/asanas) and for type of control interven-
tion (yoga versus no treatment; yoga versus active com-
parator). Moreover, subgroup analyses were conducted
for current treatment status (patients who were under-
going active cancer treatment; patients who had com-
pleted active treatment).
To test the robustness of significant results, sensitivity
analyses were conducted for studies with high or unclear
risk of selection bias (inadequate or unclear random se-
quence generation and/or allocation concealment) ver-
sus low risk of selection bias (adequate random
sequence generation and/or allocation concealment).
If statistical heterogeneity was present in the respective
meta-analysis, subgroup and sensitivity analyses were
also used to explore possible reasons for heterogeneity.
Risk of bias across studies
Publication bias was assessed by visual analysis of funnel
plots, generated using Review Manager 5 software. Fun-
nel plots were analyzed only if at least 10 studies were
included in a meta-analysis. Roughly symmetrical funnel
plots were regarded to indicate low risk while asymmet-
rical funnel plots were regarded to indicate high risk of
publication bias [22].
Results
Study selection
The literature search generated a total of 156 records, 54
of them were duplicates (Figure 1). Three additional
records were found in the International Journal of Yoga
Therapy. Eighteen full-text articles were assessed for eli-
gibility [23-40] and 6 were excluded. One article
reported effects of yoga in patients with mixed types of
cancer, not just breast cancer [37]; 1 article did not as-
sess health-related quality of life or psychological health
but natural killer cell counts [38]; 2 articles [39,40]
reported a subgroup analysis of an already published
trial [33]. Three articles reported different outcomes of 1
single trial; these articles were treated as 1 single study
[34-36]. Hence, this was regarded as 1 included article
and 2 excluded articles. Twelve RCTs, involving a total
156 of records identified through 
database searching
- 41  Pubmed
- 18  Cochrane
- 87  Embase
- 0  Cambase
- 10  PsycInfo
3 of additional records identified 
through other sources 
- 3 International Journal of  Yoga Therapy
87 of records excluded
6 of full-text articles excluded
-1 heterogeneous cancer 
population
-1 neither quality of life nor 
psychological health
-2 multiple publications on the same 
sample
-2 subsample of already published 
data
10 of studies included in 
quantitative synthesis 
(meta-analysis)
2 of full-text articles excluded
-2 insufficient raw data
105 of records after 
duplicates removed
18 of full-text articles 
assessed for eligibility 
12 of studies included in 
qualitative synthesis 
Figure 1 Flowchart of the results of the literature search.
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sis [23-36]. One RCT did not report any group compari-
sons but presented effects of the yoga intervention in a
more qualitative way and therefore was not included in
the meta-analysis [25]. One RCT did not report standard
deviations, standard errors, confidence intervals, or t-
values [27]. Since the missing data could not be obtained
from the authors of the respective study by email, this
study was excluded from the meta-analysis. Finally, 10
studies were included in the meta-analysis.
Study characteristics
Study characteristics are shown in Table 2.
Setting and participant characteristics
Eight studies originated from North America
[23,25-29,31,32], 1 from Europe [30] and 3 from India
[24,33-36]. Participants mainly were recruited from can-
cer centers [23-25,27-30,32-36], but also from private
clinics [32], tumor registries [26], and newspaper or
website advertisements [26,31].
Participants in 5 studies were receiving active cancer
treatment (i.e. chemotherapy, radiotherapy, or both)during the yoga intervention [24,28,30,33-36], partici-
pants in 5 studies had completed active treatment before
the onset of the study [23,25-27,31] and 2 studies did in-
clude both participants receiving active cancer treatment
and those who did not [29,32]. Stage of cancer was
mixed, however, only 2 studies included patients with
stage 4 breast cancer [23,29] and only 3 studies included
patients with stage 0 breast cancer [28,29,31]. Partici-
pants’ mean age ranged from 44 years to 63 years; be-
tween 0% and 100% of participants in each study were
Caucasians. One study explicitly strived to include a
multiethnic sample [32].
Yoga interventions were heterogeneous and included
an integrated yoga program [24,33-36], Iyengar yoga
[23,25,26], Yoga of Awareness [27], Viniyoga [31], re-
storative yoga [29], yoga based on Patanjali‘s yoga trad-
ition [28], Yoga in daily lifeW [30], and hatha yoga [32].
Program length and intensity varied, ranging from daily
interventions over 1 week [30] to one intervention per
week over 6 months [31]. All but 1 RCT [30] included
physical activity/asanas in their yoga intervention. Con-
trol groups were wait-listed and did not receive any
treatment in 7 studies [23,25,27-29,31,32]; received brief
Table 2 Characteristics of the included studies
Authors, year No. of
patients
Mean
age
Status
of
cancer
Current
treatment
Treatment
group:
Intervention
Control
group:
Intervention
Outcome
measures
Outcome
assessment
Results
Program
length,
frequency,
duration
Program
length,
frequency,
duration
a) Short-term
follow-up
b) Long-term
follow-up
Banasik et al.,
2011 [23]
18 62.9 II-IV At least 2
month
post-
treatment
Iyengar Yoga:
yoga postures
Wait-list, no
treatment
Health-related
quality of life (FACT-B)
No significant
effects.
8 weeks, twice
weekly, 90 minutes
8 weeks a) Week 8
b) NA
Banerjee et al.,
2007 [24]
68 44 II-III Radiotherapy Integrated yoga
program: yoga
postures, deep
relaxation,
breathing
techniques,
meditation,
guided imagery,
group awareness
Supportive
counseling and
advice to take
light exercise
Anxiety (HADS) Significant short-
term effects on
anxiety (p < 0.001),
depression (p < 0.001),
perceived stress
(p < 0.001).
6 weeks, frequency
NR, 90 minutes
6 weeks, frequency
and duration NR
Depression (HADS)
Perceived
stress (PSS)
a) Week 6
b) NA
Blank et al.,
2003 [25]
18 NR I-III Antiestrogen
or aromatase
inhibitor, at
least 8 weeks
post-
chemotherapy
Iyengar yoga: yoga
postures, deep
relaxation, meditation,
chanting
Wait-list, no
treatment
Questionnaire
regarding
perceived stress,
psychological
outcomes
No group comparison.
8 weeks, twice
weekly, duration NR
8 weeks a) Week 6
b) NA
Bower et al.,
2011 [26]
31 53.9 0-II No local
and/or
adjuvant
cancer
therapy
Iyengar yoga: postures,
breathing techniques
Health education Vitality (SF-36) Significant short-term
effects on depression
(p = 0.026).
12 weeks, twice
weekly, 90 minutes
12 weeks, once
weekly, 120
minutes
Depression (BDI)
Clinically important
long-term effects
on vitality.
Perceived
stress (PSS)
a) weeks
12 to 14
b) week 24
Carson et al.,
2009 [27]
37 54.4 I-II No current
chemotherapy
or hormone
replacement
therapy
Yoga of Awareness:
yoga postures,
breathing techniques,
meditation, study of
pertinent topics,
group discussion
Wait-list, no
treatment
Daily diary
regarding
negative mood,
symptom-
related distress
Significant short-term
effects on symptom-
related distress
(p < 0.0001).
8 weeks, once
weekly, 120 minutes
8 weeks a) Week 6 Significant long-term
effects on symptom-
related distress
(p < 0.0001) and
negative mood
(p < 0.0001).
b) Week 20
Chandwani
et al., 2010 [28]
81 NR 0-III Radiotherapy Yoga based on
Patanjali`s yoga
sutras: yoga postures,
deep relaxation,
breath control,
meditation
Wait-list, no
treatment
Health-related
quality of life
(SF-36)
Significant short-term
effects on SF-36
physical component
score (p = 0.04),
general health
(p = 0.005), physical
function (p = 0.04).
6 weeks, twice
weekly, 60 minutes
6 weeks
Depression (CES-D)
No significant long-
term effects.
Anxiety (STAI)
Intrusion/avoidance (IES)
a) Week 7
b) Week 18
Danhauer et al.,
2009 [29]
44 55.8 Any Any Restorative yoga:
yoga postures,
breathing techniques,
deep relaxation,
meditation
Wait-list, no
treatment
Health-related quality
of life (FACT-B,
FACIT-Sp, SF-12)
Significant short-
term effects on
mental well-being
(p = 0.004), spiritual
well-being (p = 0.0009),
depression (p = 0.026),
positive affect
(p = 0.01).
10 weeks, once
weekly, 75 minutes
10 weeks
Depression (CES-D)
Positive and negative
affect (PANAS)
a) Week 10
b) NA
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Kovačič & Kovačič,
2011 [30]
32 NR I-II Radiotherapy,
chemotherapy
Yoga in Daily LifeW
System: breathing
techniques, deep
relaxation, progressive
muscle relaxation,
meditation
Standard
physiotherapy
Mental well-being
(GHQ-12)
Significant short-term
effects on mental
well-being (p < 0.0005),
perceived stress
(p < 0.0005).
1 week, 7 times a
week, 45 minutes
1 week
Psychological
distress (RSCL)
Significant long-term
effects on mental
well-being (p < 0.0005),
psychological distress
(p < 0.0005), perceived
stress (p < 0.0005).
Standard
physiotherapy
Perceived
stress (PSS)
1 week
a) Week 2
b) Week 5
Littman et al.,
2011 [31]
63 60.6 0-III At least 3
month
post-
treatment
Viniyoga: yoga
postures, breathing
techniques, deep
relaxation, meditation
Wait-list, no
treatment
Health-related
quality of life
(FACT-B)
No significant effects.
6 months, 1 to 3
times a week
75 minutes
6 month a) Week 48
b) NA
Moadel et al.,
2007 [32]
164 54.81 I-III Any Hatha yoga: yoga
postures, breathing,
techniques,
meditation
Wait-list, no
treatment
Health-related
quality of life
(FACT-G, FACIT-Sp)
Significant short-term
effect on social
well-being (p < 0.018).
12 weeks, once
weekly, 90 minutes
12 weeks
Anxiety (Distressed
Mood Index)
Psychological
distress (Distressed
Mood Index)
a) Week 12
b) Week 24 (NR)
Raghavendra
et al., 2007 [33]
98 NR II-III Chemotherapy Integrated yoga
program: yoga
postures, breathing
techniques, relaxation
with imagery,
chanting
Brief supportive
therapy
Health-related
quality of life (FLIC)
Significant short-term
effects on overall
health-related quality
of life (p < 0.001),
anxiety (p < 0.001),
depression (p < 0.001),
symptom distress
(p < 0.001).
Program length NR,
30 minutes 4 times,
60 minutes every
10 days
Program length
NR, 60 minutes
once, 30 minutes
every 10 days
Anxiety (STAI)
Depression (BDI)
Symptom distress
(Subjective
Symptom Checklist)
a) NR
b) NA
Vadiraja et al.,
2009 [34-36]
88 47.23 II-III Radiotherapy Integrated yoga
program: yoga
postures, breathing
techniques, relaxation
with imagery,
meditation
Brief supportive
therapy
Health-related
quality of life
(EORTC
QLQ-C30)
Anxiety (HADS)
Depression
(HADS)
Positive and
negative affect
(PANAS)
Significant short-term
effects on emotional
function (p = 0.001),
cognitive function
(p = 0.03), anxiety
(p < 0.001), depression
(p = 0.002), positive
affect (p = 0.007),
negative affect
(p < 0.001), perceived
stress (p < 0.001),
psychological distress
(p < 0.001).
6 weeks, 60 minutes
at least 3 times a
week (18–24 session
in total)
6 weeks, 15
minutes every
10 days (3–4
sessions in total)
Perceived
stress (PSS)
Psychological
distress (RSCL)
a) Week 6
b) NA
Abbreviations: BDI: Beck’s Depression Inventory; CES-D: Center of Epidemiologic Studies Depression Scale; EORTC QLQ-C30: European Organisation for Research
and Treatment of Cancer Quality of Life Questionnaire C30; FACT: Functional Assessment of Cancer Therapy (B: Breast; G: General; Sp: Spirituality); FLIC: Functional
Living Index for Cancer; GHQ-12: General Health Questionnaire-12; HADS: Hospital Anxiety and Depression Scale; IES: Impact of Events Scale; PANAS: Positive &
negative affect schedule; PSS: support cancer care; RSCL: Rotterdam Symptom Checklist; STAI: State Trait Anxiety Inventory; SF-36/-12: Medical Outcomes Study 36/
12-item short-form survey; NA: not applicable; NR: not reported.
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or received health education classes in 1 study [26]. One
study compared yoga combined with physiotherapy to
physiotherapy alone [30]. No study exactly matched pro-
gram length, frequency and duration of the control
intervention with the yoga intervention.
Outcome measures
Health-related quality of life Group comparisons for
health-related quality of life were reported in 8 studies
[23,28-36]. Functional Assessment of Cancer Therapy-
General was used in 1 study [32], Functional Assessment
of Cancer Therapy-Breast was used in 3 studies [23,29,31],
and Functional Assessment of Chronic Illness Therapy-
Spirituality was used in 2 studies [29,32]. Medical
Outcomes Study 36-item short-form survey [28], Medical
Outcomes Study 12-item short-form survey [29], Func-
tional Living Index for Cancer [33], General Health
Questionnaire-12 [30] and European Organization for
Research and Treatment of Cancer Quality of Life
Questionnaire C30 [35] were used in 1 study each.
Psychological health Eight studies reported group
differences for measures of psychological health
[24,26,28-30,32-36]. Of the 5 studies that assessed
anxiety, 2 used the Hospital Anxiety and Depression Scale
[24,34-36], 2 used the State Trait Anxiety Inventory
[28,33], and 1 used the Distressed Mood Index [32]. De-
pression was assessed in 6 studies. Two studies used the
Hospital Anxiety and Depression Scale [24,34-36], 2 used
the Center of Epidemiologic Studies Depression Scale
[28,29], and 2 used the Becks Depression Inventory [26,33].
Perceived stress was assessed in 4 studies, all using
the Perceived Stress Scale [24,26,30,34-36]. Six studies
assessed psychological distress, 1 of those used theTable 3 Risk of bias assessment of the included studies using
Bias Random
sequence
generation
(selection bias)
Allocation
concealment
(selection bias)
Blinding
participa
and pers
(perform
Authors, year
Banasik et al., 2011 [23] Unclear Unclear High risk
Banerjee et al., 2007 [24] Low risk Low risk High risk
Blank et al., 2003 [25] Unclear Unclear High risk
Bower et al., 2011 [26] Low risk Low risk High risk
Carson et al., 2009 [27] Low risk Low risk High risk
Chandwani et al., 2010 [28] Low risk Unclear High risk
Danhauer et al., 2009 [29] Unclear Unclear High risk
Kovačič & Kovačič, 2011 [30] Low risk Low risk Low risk
Littman et al., 2011 [31] Low risk Unclear High risk
Moadel et al., 2007 [32] Unclear Unclear High risk
Raghavendra et al., 2007 [33] Low risk Low risk High risk
Vadiraja et al., 2009 [34-36] Low risk Low risk High riskRotterdam Symptom Check List [30], 2 used the Positive
and Negative Affect Scale [29,34-36], 1 used the Distressed
Mood Index [32], 1 used the impact of event scale [28],
and 1 used the Subjective Symptom Checklist [33].
Risk of bias in individual studies
Risk of bias for each study is shown in Table 3. No study
fulfilled all criteria. Generally, risk of selection bias was
high; 6 out of 12 studies did not report adequate random
sequence generation and/or allocation concealment
[23,25,28,29,31,32]. While no study reported blinding of
patients or yoga providers, 1 study reported blinding of
all health care providers and involved personnel [30].
Outcome assessors were blinded to treatment allocation
in 3 studies [26,27,30]. Four studies had high risk of at-
trition bias due to high and/or unbalanced drop-out
rates [24,25,33-36] and 2 studies had high risk of select-
ive reporting bias [25,34-36]. One study was judged to
have high risk of other bias, since no outcomes were
reported for the control group and no formal statistics
were conducted [25].
Analyses of overall effects
Health-related quality of life
Meta-analysis revealed evidence for a moderate short-
term effect of yoga on global health-related quality of life
(SMD=0.62; 95% CI: 0.04 to 1.21; P = 0.04). There was
no evidence for improved mental (SMD=0.45; 95% CI:
-0.06 to 0.96; P = 0.08) or physical well-being (SMD=
0.45; 95% CI: -0.19 to 1.08; P = 0.17) at the short-term.
Significant small short-term effects were found favoring
the yoga groups for functional (SMD=0.30; 95% CI: 0.03
to 0.57; P = 0.03), social (SMD=0.29; 95% CI: 0.08 to
0.50; P < 0.01) and spiritual well-being (SMD=0.41; 95%
CI: 0.08 to 0.74; P = 0.01) (Figure 2). At long-termthe Cochrane risk of bias tool
of
nts
onnel
ance bias)
Blinding of
outcome
assessment
(detection bias)
Incomplete
outcome data
(attrition bias)
Selective
reporting
(reporting
bias)
Other bias
Unclear Low risk Low risk Low risk
Unclear High risk Low risk Low risk
Unclear High risk High risk High risk
Low risk Low risk Low risk Low risk
Low risk Low risk Low risk Low risk
Unclear Low risk Low risk Low risk
Unclear Low risk Low risk Low risk
Low risk Unclear Low risk Low risk
High risk Low risk Low risk Low risk
Unclear Low risk Low risk Low risk
Unclear High risk Low risk Low risk
Unclear High risk High risk Low risk
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well-being (SMD=2.36; 95% CI: -2.02 to 6.74; P = 0.29)
(Figure 2).
Psychological health
Evidence for large short-term effects was found for anx-
iety (SMD=−1.51; 95% CI: -2.47 to −0.55; P < 0.01), de-
pression (SMD=−1.59; 95% CI: -2.68 to −0.51; P < 0.01),
perceived stress (SMD=−1.14; 95% CI: -2.16 to −0.12;
P = 0.03), and psychological distress (SMD=−0.86; 95%
CI: -1.50 to −0.22; P < 0.01) (Figure 3). The effects on de-
pression (SMD=−0.36; 95% CI: -0.80 to 0.07; P = 0.10),
perceived stress (SMD=−1.76; 95% CI: -5.08 to 1.56;
P = 0.14) and psychological distress (SMD=−1.73; 95%
CI: -4.02 to 0.56; P = 0.14) were not maintained at the
long-term follow-up (Figure 3).
Safety
Three studies reported adverse events [26,29,31]. Only 1
adverse event was reported (out of 138 patients): 1 par-
ticipant experienced a transient back spasm during class
[26]. The other 2 studies stated that no adverse events
were reported [29,31].
Subgroup analyses
The results did not change substantially when only stud-
ies that included physical activity/asanas in their yoga
intervention were considered [23-29,31-36]. As only 1
study did not include physical activity/asanas [30], no
separate analysis was conducted.
When comparing yoga to no treatment, small short-
term effects were found for global quality of life, func-
tional, social, and spiritual well-being, but not for mental
well-being, physical well-being, anxiety, depression, and
psychological distress (Table 4). When comparing yoga
to an active control intervention, evidence for large
short-term effects was found for mental well-being, anx-
iety, depression, perceived stress, and psychological dis-
tress (Table 4).
In studies in which the intervention was administered
to patients who were undergoing active treatment
[24,28,30,33-36], no evidence for short-term effects was
found for mental, physical, or social, well-being. Evi-
dence for large short-term effects was found for anxiety,
depression, perceived stress, and psychological distress
(Table 5). For studies in which the participants had com-
pleted active treatment [23,25-27,31], meta-analyses on
2 RCTs did not find any group differences in mental,
physical, functional, or social well-being (Table 5).
Sensitivity analysis
Sensitivity analyses demonstrated a significant short-
term effect on general health-related quality of life, func-
tional, social, and spiritual well-being in studies withunclear or high risk of selection bias whereas these
effects were not significant in studies with low risk of
selection bias. Short-term effects on anxiety, depres-
sion, perceived stress, and psychological distress were
significant in studies with low risk of selection bias but
not in studies with unclear or high risk of selection bias.
Publication bias
Due to the small number of eligible studies, funnel plots
were not analyzed.
Discussion
Previous systematic reviews found favorable effects of
yoga interventions on health-related quality of life and
psychological health in cancer patients and survivors
[15,16]. However, none of these reviews focused only on
women with breast cancer.
The aim of the present review was to systematically
evaluate the totality of evidence for the efficacy of yoga
on health-related quality of life and psychological health
in breast cancer patients and survivors. This review
found a moderate size short-term effect on global
health-related quality of life along with small size short-
term effects on functional, social, and spiritual quality of
life. Regarding psychological health, large short-term
effects on anxiety, depression, perceived stress, and psy-
chological distress were found. At the moment there is
no evidence for longer-term effects of yoga in breast
cancer patients and survivors. More RCTs with longer
follow-ups are needed. The available safety data suggest
that yoga is not associated with serious adverse events.
However, future RCTs should ensure more rigorous
reporting of adverse events and reasons for drop-outs.
The findings in this review are partly in line with a
previous meta-analysis on yoga for heterogeneous cancer
populations, which reported positive effects on psycho-
logical health while finding no effects in health-related
quality of life [15]. However, meta-analyses focusing on
physical activity (not including yoga) for breast cancer
patients and survivors reported positive effects on qual-
ity of life [12,13].
Besides physical activity, yoga also encompasses
breathing techniques and meditation [10]. While medita-
tion on its own may have a positive impact on psycho-
logical health in cancer patients [19,41], studies have
also demonstrated specific positive effects of physical
yoga postures on mood [42].
The finding that yoga was more effective during active
cancer treatment than after completion of cancer treat-
ment is in contrast to a prior RCT, that reported more
favorable results in a subgroup of breast cancer patients
that were not receiving chemotherapy [32]. The findings
in this meta-analysis might result from the small number
of studies that could be included in the meta-analyses
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Figure 2 Effect sizes of yoga versus controls on health-related quality of life: general quality of life, mental, physical, social, and
spiritual well-being.
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Figure 3 Effect sizes of yoga versus controls on psychological health: anxiety, depression, perceived stress, and psychological distress.
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Table 4 Effect sizes of yoga versus no treatment and active control interventions
Outcomea No. of
studies
No. of
patients
(yoga)
No. of
patients
(control)
Standardized
mean difference
[95% confidence interval]
P (overall
effect)
Heterogeneity
I2; Chi2; P
Yoga versus no treatment
Short-term
Global quality of life 3 127 85 0.29 [0.01, 0.57] 0.04 0%; 0.75; 0.69
Mental well-being 5 161 123 0.09 [−0.15, 0.33] 0.46 0%; 3.40; 0.49
Physical well-being 5 161 123 0.51 [−0.33, 1.34] 0.23 89%; 37.26; <0.01
Functional well-being 4 134 92 0.30 [0.03, 0.57] 0.03 0%; 1.14; 0.77
Social well-being 3 161 123 0.32 [0.08, 0.56] <0.01 0%; 3.49; 0.48
Spiritual well-being 2 97 58 0.41 [0.08, 0.74] 0.01 0%; 0.11; 0.74
Anxiety 2 111 75 −0.58 [−1.22, 0.07] 0.08 75%; 3.93; 0.05
Depression 2 40 45 −0.35 [−0.81, 0.12] 0.14 11%; 1.12; 0.29
Psychological distress 3 124 89 −0.19 [−0.70, 0.32] 0.47 64%; 5.55; 0.06
Yoga versus active control interventions
Short-term
Mental well-being 2 63 60 1.19 [0.13, 2.26] 0.03 81%; 5.9; 0.02
Anxiety 3 105 90 −2.21 [−3.90, -0.52] 0.01 95%; 42.26; <0.01
Depression 4 121 105 −2.29 [−3.97, -0.61] <0.01 96%; 74.01; <0.01
Perceived stress 3 93 71 −1.14 [−2.16, -0.12] 0.03 88%; 16.42; <0.01
Psychological distress 3 91 94 −1.55 [−2.48, -0.61] <0.01 85%; 13.68; <0.01
aOutcomes are only shown when sufficient data for meta-analysis were available.
Table 5 Effect sizes of yoga versus control during active cancer treatment and after completion of active cancer
treatment
Outcomea No. of
studies
No. of
patients
(yoga)
No. of
patients
(control)
Standardized mean
difference [95%
confidence interval]
P (overall
effect)
Heterogeneity
I2; Chi2; P
During active cancer treatment
Short-term
Mental well-being 3 90 91 1.01 [−0.19, 2.22] 0.10 92%; 24.89; <0.01
Physical well-being 3 81 82 1.22 [−0.90, 3.34] 0.26 97%; 28.66; <0.01
Social well-being 2 74 75 0.38 [−0.02, 0.78] 0.06 31%; 1.46; 0.23
Anxiety 4 132 121 −1.86 [−3.02, -0.69] <0.01 93%; 45.00;<0.01
Depression 4 132 121 −2.16 [−3.77, -0.55] <0.01 96%; 83.03; <0.01
Perceived stress 3 93 72 −2.13 [−3.48, -0.78] <0.01 91%; 21.38; <0.01
Psychological distress 4 113 114 −1.10 [−2.09, -0.10] 0.03 92%; 35.97; <0.01
After active cancer treatment
Short-term
Mental well-being 2 37 34 −0.16 [−0.63, 0.31] 0.50 0%; 0.04; 0.85
Physical well-being 2 37 34 0.07 [−0.68, 0.81] 0.86 44%; 1.77; 0.18
Functional well-being 2 37 34 0.23 [−0.23, 0.70] 0.33 0%; 0.05; 0.82
Social well-being 2 37 34 0.05 [−0.50, 0.61] 0.85 16%; 1.20; 0.27
aOutcomes are only shown when sufficient data for meta-analysis were available.
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ited the power of these analyses. Moreover, the respect-
ive studies did not require participants to have
impairments of health-related quality of life or psycho-
logical health to be eligible, hence, leaving little room for
improvement.
External and internal validity
The included studies were conducted in primary, sec-
ondary, and tertiary care settings in North America,
Europe, or Asia. Participants were mainly adult Caucasians
and Asians but other ethnicities were also included.
Patients with stage 0 to IV breast cancer and patients
undergoing active cancer treatment as well as survivors
who had completed active treatment were included.
Most studies included mainly well educated women with
high socioeconomic status and resulting good access to
health care. However, 1 study explicitly aimed to include
an ethnically diverse sample of breast cancer patients from
an underserved urban community. The results of this re-
view are therefore applicable to the vast majority of
breast cancer patients and survivors in clinical practice.
There was a great variability of risk of bias in included
studies. Blinding participants or care providers might
not be possible in yoga studies [43]. However, blinding
of outcome assessment is even more important and
only 3 studies reported blinding of outcome assessors
[26,27,30]. Randomization and/or allocation concealment
were inadequate in 50% of the included studies and the
effects on health-related quality of life were not distin-
guishable from selection bias. These issues might limit
internal validity of the results regarding quality of life.
In subgroup analyses, effects on psychological health
were only present in studies on patients undergoing ac-
tive cancer treatment. Therefore, the results of this re-
view are only applicable to breast cancer patients who
are undergoing active treatment.
Strengths and weaknesses
This is the first available systematic review and meta-
analysis on yoga for breast cancer patients and survivors.
Moreover, effects were analyzed separately for patients in
different phases of active cancer treatment. Since adequate
randomization and allocation concealment have been
recommended as the most important safeguard against
bias [44], effects of risk of selection bias were assessed.
The primary limitation of this review is the small total
number of eligible RCTs. As only studies that were pub-
lished as a full paper were eligible, this review might
have missed RCTs that were unpublished or published
as dissertation or abstract only. Moreover, as only 3
RCTs included a long-term follow-up, long-term effects
could not be estimated for all pre-specified outcome
measures and analyses were limited by the low numberof included studies. Interpretability of results is limited
by high risk of selection bias and detection bias. Hetero-
geneity of yoga interventions regarding yoga tradition,
length of the program and frequency of the intervention
might further limit the interpretation of the results. At
the moment, it is impossible to make claims on whether
the yoga style or other characteristics of the intervention
have any impact on the efficacy of the program. Statis-
tical heterogeneity was high in most meta-analysis; 10
out of 14 comparisons showed considerable heterogen-
eity. Due to the low number of included studies, sub-
group and sensitivity analyses could not provide reasons
for heterogeneity in the remaining meta-analyses.
Conclusions
Given the short period of time yoga has been regarded as
a treatment option for breast cancer patients [45], the evi-
dence reviewed here has to be regarded as preliminary.
Some large studies on yoga for breast cancer patients are
currently conducted by major US cancer centers [46] that
will surely add new and possibly conflicting evidence.
Until then, the clearly positive effects of yoga on psycho-
logical health in breast cancer patients should warrant its
use in this patient population. Yoga might be particularly
recommended as an intervention to improve psychological
health during active breast cancer treatment.
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